Cited by CrossRef (25)
- Jung Hee Koh, Yusun Lee, Hyoun-Ah Kim, Jinhyun Kim, Kichul Shin. Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry. Therapeutic Advances in Musculoskeletal 2022;14

- Seulkee Lee, Seonyoung Kang, Hyungjin Kim, Jaejoon Lee, Min-Ji Kim, Hoon-Suk Cha. Sex-specific disparities in disease activity scores among patients with axial spondyloarthritis and their implications for evaluating the response to tumor necrosis factor alpha inhibitor therapy. Arthritis Res Ther 2024;26

- Oh Chan Kwon, Min-Chan Park. Drug Retention Rate and Factors Associated with Discontinuation of Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis. Yonsei Med J 2023;64:697

- Young Ho Lee, Gwan Gyu Song. Association between the functional FCGR3AF158V and FCGR2AR131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta‐analysis. Int J of Rheum Dis 2023;26:1295

- Jung Gon Kim, Bon San Koo, Joo-Hyun Lee, Bo Young Yoon. Anemia as an indicator of a higher retention rate for tocilizumab versus tumor necrosis factor inhibitors in patients with rheumatoid arthritis from a Korean multicenter registry. J Rheum Dis 2024;31:212

- Young Ho Lee, Gwan Gyu Song. Associations between the interleukin-6 rs1800795 G/C and interleukin-6 receptor rs12083537 A/G polymorphisms and response to disease-modifying antirheumatic drugs in rheumatoid arthritis: A meta-analysis. International Immunopharmacology 2022;112:109184

- Young Ho Lee, Gwan Gyu Song. Relative effectiveness and safety of interleukin-6 and Janus kinase inhibitors versus adalimumab in patients with rheumatoid arthritis: a network meta-analysis. Z Rheumatol 2023;82:696

- Ji-Won Kim, Eunyoung A. Lee, Hyoun-Ah Kim, Chang-Hee Suh, Ju-Yang Jung. Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry. BioDrugs 2022;36:411

- Sun-Kyung Lee, Kichul Shin, Ju-Yang Jung, Chang-Hee Suh, Ji-Won Kim, Hyoun-Ah Kim. Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study. BioDrugs 2023

- Ayu Paramaiswari, Deddy Nur Wachid Achadiono, Nyoman Kertia, Dhite Bayu Nugroho, Min Jung Kim, Kichul Shin. Establishing the Indonesian Systemic Lupus Erythematosus Regional (ISLET) Registry: Aftermath of the Asia Pacific League of Associations for Rheumatology (APLAR) Center of Excellence Exchange Program. Int J of Rheum Dis 2024;27

- Jun Won Park, Ju Yeon Kim, Min Jung Kim, Yoo Kyoung Lim, Hyoun-Ah Kim, Jin Hyun Kim, Kichul Shin. Impact of concomitant methotrexate on disease activity in patients with rheumatoid arthritis tapering abatacept: results from KOBIO registry. Front. Med. 2024;11

- Min Jung Kim, Sun-Kyung Lee, Sohee Oh, Hyoun-Ah Kim, Yong-Beom Park, Shin-Seok Lee, Kichul Shin. Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry. Rheumatol Ther 2022;9:1143

- Young Ho Lee. Comparative Efficacy and Safety of Janus Kinase Inhibitors and Secukinumab in Patients with Active Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. Pharmacology 2022;107:537

- Seong-Ryul Kwon, Tae-Hwan Kim, Tae-Jong Kim, Won Park, Seung Cheol Shim. The Epidemiology and Treatment of Ankylosing Spondylitis in Korea. J Rheum Dis 2022;29:193

- Hong Ki Min, Se Hee Kim, Sang-Heon Lee, Hae-Rim Kim. Risk factors for interstitial lung disease in rheumatoid arthritis: a cohort study from the KOBIO registry. Therapeutic Advances in Musculoskeletal 2024;16

- Bora Nam. Optimization of biological therapy selection in rheumatoid arthritis: insights into anemia and interleukin-6 pathway. J Rheum Dis 2025;32:1

- Young Ho Lee, Gwan Gyu Song. Relative efficacy and safety of Janus kinase inhibitors for the treatment of active psoriatic arthritis: a network meta-analysis. Z Rheumatol 2023;82:408

- Hyoun-Ah Kim, So Young Park, Kichul Shin. Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry. J Rheum Dis 2022;29:215

- Dong-Jin Park, Hyemin Jeong, Sung-Eun Choi, Ji-Hyoun Kang, Shin-Seok Lee. Impact of obesity on clinical outcomes and treatment continuation in rheumatoid arthritis patients receiving non-TNF-targeted therapies. Therapeutic Advances in Musculoskeletal 2024;16

- Jisoo Lee, Yoon-Kyoung Sung, Myeung-Su Lee, Han Joo Baek. The Korean College of Rheumatology: 40 Years of Public Health Influence. J Rheum Dis 2022;29:75

- Soo Min Ahn, Young Bin Joo, Yun Jin Kim, So-Young Bang, Hye-Soon Lee. Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases. J Korean Med Sci 2023;38

- Jinhyun Kim, Min Jung Kim, Geun Young Oh, Sun Kyung Lee, Taeeun Kim, Kichul Shin. The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry. Therapeutic Advances in Musculoskeletal 2023;15

- Hyoun-Ah Kim, Eunyoung Lee, So Young Park, Shin-Seok Lee, Kichul Shin. Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy. J Korean Med Sci 2022;37

- M. Kwon, C. I. Joung, H. Shin, C. C. Lee, Y. S. Song, Y. J. Lee, S. Kang, J. Y. Kim, S. Lee. Detection of novel drug-adverse drug reaction signals in rheumatoid arthritis and ankylosing spondylitis: analysis of Korean real-world biologics registry data. Sci Rep 2024;14

- Ju-Yang Jung, Eunyoung Lee, Ji-Won Kim, Chang-Hee Suh, Kichul Shin, Jinhyun Kim, Hyoun-Ah Kim. Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry. Arthritis Res Ther 2023;25
